- Home
- AMD vs NVS Comparison
AMD vs NVS Comparison
Compare AMD & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMD
- NVS
- Stock Information
- Founded
- AMD 1969
- NVS 1895
- Country
- AMD United States
- NVS Switzerland
- Employees
- AMD N/A
- NVS N/A
- Industry
- AMD Semiconductors
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- AMD Technology
- NVS Health Care
- Exchange
- AMD Nasdaq
- NVS Nasdaq
- Market Cap
- AMD 205.6B
- NVS 230.5B
- IPO Year
- AMD 1972
- NVS 1991
- Fundamental
- Price
- AMD $136.27
- NVS $123.61
- Analyst Decision
- AMD Buy
- NVS Hold
- Analyst Count
- AMD 37
- NVS 6
- Target Price
- AMD $143.47
- NVS $123.67
- AVG Volume (30 Days)
- AMD 54.4M
- NVS 1.2M
- Earning Date
- AMD 07-29-2025
- NVS 07-17-2025
- Dividend Yield
- AMD N/A
- NVS 2.11%
- EPS Growth
- AMD 99.41
- NVS N/A
- EPS
- AMD 1.37
- NVS 6.38
- Revenue
- AMD $27,750,000,000.00
- NVS $53,222,000,000.00
- Revenue This Year
- AMD $24.09
- NVS $7.22
- Revenue Next Year
- AMD $17.65
- NVS $1.94
- P/E Ratio
- AMD $99.36
- NVS $19.28
- Revenue Growth
- AMD 21.71
- NVS 11.50
- 52 Week Low
- AMD $76.48
- NVS $96.06
- 52 Week High
- AMD $187.28
- NVS $123.82
- Technical
- Relative Strength Index (RSI)
- AMD 63.71
- NVS 69.89
- Support Level
- AMD $135.12
- NVS $115.43
- Resistance Level
- AMD $147.75
- NVS $119.29
- Average True Range (ATR)
- AMD 4.91
- NVS 1.24
- MACD
- AMD 0.40
- NVS 0.36
- Stochastic Oscillator
- AMD 64.87
- NVS 95.95
About AMD Advanced Micro Devices Inc.
Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers, industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox. In 2022, the firm acquired field-programmable gate array leader Xilinx to diversify its business and augment its opportunities in key end markets such as data center and automotive.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.